Clinical Trials Logo

Recurrent Glioblastoma or Other Glioma Subtypes clinical trials

View clinical trials related to Recurrent Glioblastoma or Other Glioma Subtypes.

Filter by:
  • None
  • Page 1

NCT ID: NCT01975701 Active, not recruiting - Clinical trials for Recurrent Glioblastoma or Other Glioma Subtypes

A Phase 2 Study of BGJ398 in Patients With Recurrent GBM

Start date: December 9, 2013
Phase: Phase 2
Study type: Interventional

This is an open-label non-randomized, multicenter, phase II study of BGJ398 administered to adult patients with histologically confirmed GBM and/or other glioma subtypes with FGFR1-TACC1, FGFR3-TACC3 fusion and/or activating mutation in FGFR1, 2 or 3.